Adjunctive Linezolid for the Treatment of Tuberculous Meningitis
Phase 2
Completed
- Conditions
- Tuberculosis, Meningeal
- Interventions
- Drug: LZDDrug: High dose RIFDrug: Standard dose RIF
- First Posted Date
- 2019-07-16
- Last Posted Date
- 2024-10-01
- Lead Sponsor
- University of California, San Francisco
- Target Recruit Count
- 40
- Registration Number
- NCT04021121
- Locations
- 🇺🇬
Masaka Regional Referral Hospital/MRC UVRI Uganda Research Unit on AIDS, Masaka, Uganda
Autonomic Mechanisms of Sleep-dependent Memory Consolidation
Not Applicable
Terminated
- Conditions
- SleepMemory
- Interventions
- Device: transcutaneous vagal nerve stimulation
- First Posted Date
- 2019-07-16
- Last Posted Date
- 2021-05-28
- Lead Sponsor
- University of California, San Francisco
- Target Recruit Count
- 12
- Registration Number
- NCT04021797
- Locations
- 🇺🇸
Langley Porter Psychiatric Institute, San Francisco, California, United States
Development of a Mobile App for an Executive Functioning Intervention for Adolescents
Not Applicable
Completed
- Conditions
- Attention Deficit Hyperactivity Disorder Symptoms
- Interventions
- Device: Behavioral/organizational skills intervention augmented with digital health application
- First Posted Date
- 2019-07-15
- Last Posted Date
- 2021-11-23
- Lead Sponsor
- University of California, San Francisco
- Target Recruit Count
- 15
- Registration Number
- NCT04018794
- Locations
- 🇺🇸
University of California, San Francisco, San Francisco, California, United States
Behavioral Approaches to Reducing Diabetes Distress and Improving Glycemic Control
Not Applicable
Completed
- Conditions
- Diabetes DistressType 1 Diabetes
- Interventions
- Behavioral: FixItBehavioral: StreamLineBehavioral: TunedIn
- First Posted Date
- 2019-07-11
- Last Posted Date
- 2023-12-26
- Lead Sponsor
- University of California, San Francisco
- Target Recruit Count
- 276
- Registration Number
- NCT04016558
- Locations
- 🇺🇸
University of California, San Francisco, San Francisco, California, United States
Treatment of Disturbed Sleep in Progressive Supranuclear Palsy (PSP)
Phase 4
Recruiting
- Conditions
- Treatment
- Interventions
- First Posted Date
- 2019-07-10
- Last Posted Date
- 2023-10-27
- Lead Sponsor
- University of California, San Francisco
- Target Recruit Count
- 60
- Registration Number
- NCT04014387
- Locations
- 🇺🇸
University of California- San Francisco, San Francisco, California, United States
Controlled Exposure of Healthy Nonsmokers to Secondhand and Thirdhand Cigarette Smoke
Not Applicable
Suspended
- Conditions
- Pollution; ExposureSmoke InhalationExposure to Pollution
- Interventions
- Other: Cigarette SmokeOther: Clean Air and Clean Clothing/Sham exposure
- First Posted Date
- 2019-07-09
- Last Posted Date
- 2023-08-28
- Lead Sponsor
- University of California, San Francisco
- Target Recruit Count
- 66
- Registration Number
- NCT04013256
- Locations
- 🇺🇸
Zuckerberg San Francisco General Hospital, San Francisco, California, United States
Brigatinib and Binimetinib in Treating Patients With Stage IIIB-IV ALK or ROS1-Rearranged Non-small Cell Lung Cancer
Phase 1
Terminated
- Conditions
- ALK Gene RearrangementLung Non-Small Cell CarcinomaProgressive DiseaseStage IV Lung CancerStage IIIC Lung CancerStage IVA Lung CancerROS1 Gene RearrangementStage IVB Lung CancerStage IIIB Lung Cancer
- Interventions
- First Posted Date
- 2019-07-02
- Last Posted Date
- 2022-10-17
- Lead Sponsor
- University of California, San Francisco
- Target Recruit Count
- 3
- Registration Number
- NCT04005144
- Locations
- 🇺🇸
University of California, San Francisco, San Francisco, California, United States
CenteringPregnancy Oral Health Promotion
Not Applicable
Withdrawn
- Conditions
- Oral Health
- Interventions
- Other: CPOP Intervention
- First Posted Date
- 2019-06-28
- Last Posted Date
- 2023-01-23
- Lead Sponsor
- University of California, San Francisco
- Registration Number
- NCT04001933
Assessment and Prevention of Pain During Ovarian Stimulation in Patients With Endometriosis
Phase 2
Active, not recruiting
- Conditions
- EndometriosisOvarian Hyperstimulation
- Interventions
- Drug: Placebo oral tabletDrug: Letrozole
- First Posted Date
- 2019-06-28
- Last Posted Date
- 2023-11-18
- Lead Sponsor
- University of California, San Francisco
- Target Recruit Count
- 65
- Registration Number
- NCT04002141
- Locations
- 🇺🇸
UCSF Center for Reproductive Health, San Francisco, California, United States
Physical Activity and Fertility Care Study
Not Applicable
Completed
- Conditions
- Infertility, Female
- Interventions
- Behavioral: Sufficient physical activityBehavioral: Insufficient physical activity
- First Posted Date
- 2019-06-28
- Last Posted Date
- 2023-12-27
- Lead Sponsor
- University of California, San Francisco
- Target Recruit Count
- 215
- Registration Number
- NCT04002414
- Locations
- 🇺🇸
UCSF Medical Center at Mission Bay, San Francisco, California, United States
© Copyright 2025. All Rights Reserved by MedPath